<p>MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway</p>Zhilai Lin, Yuhua Chen|OncoTargets and Therapy|2020Cited by 38